Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
M/I Homes
MHO
$3.83B
| $5.08M | ﹤0.01% |
87,902
-4,567
| -5% | -$280K |
|
2802
Perion Network
PERI
$382M
| $5.07M | ﹤0.01% |
292,772
-187,752
| -39% | -$3.58M |
|
|
PSTH
2803
CALL
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $5.07M | ﹤0.01% |
257,400
| – | – |
|
2804
Enviri
NVRI
$628M
| $5.07M | ﹤0.01% |
299,006
+61,530
| +26% | +$1.14M |
|
|
WCC
2805
WESCO International
WCC
$16.4B
| $5.06M | ﹤0.01% |
43,894
-109,471
| -71% | -$12.1M |
|
|
LCIDW
2806
CALL
DELISTED
Lucid Group, Inc. Warrant
LCIDW
| $5.05M | ﹤0.01% |
447,264
| – | – |
|
|
HUGS
2807
DELISTED
USHG Acquisition Corp.
HUGS
| $5.05M | ﹤0.01% |
520,013
-49,318
| -9% | -$478K |
|
|
GGMC
2808
DELISTED
Glenfarne Merger Corp. Class A Common Stock
GGMC
| $5.05M | ﹤0.01% |
521,066
+105,638
| +25% | +$1.03M |
|
2809
Main Street Capital
MAIN
$5.47B
| $5.04M | ﹤0.01% |
122,739
+59,849
| +95% | +$2.49M |
|
2810
CALL
United States Natural Gas Fund
UNG
$520M
| $5.04M | ﹤0.01% |
+62,500
| New | +$3.77M |
|
|
MLAC
2811
DELISTED
Malacca Straits Acquisition Company Limited Class A Ordinary Shares
MLAC
| $5.04M | ﹤0.01% |
507,082
+59,052
| +13% | +$585K |
|
|
KAMN
2812
DELISTED
Kaman Corp
KAMN
| $5.04M | ﹤0.01% |
141,173
+136,435
| +2,880% | +$5.63M |
|
|
PV
2813
DELISTED
Primavera Capital Acquisition Corporation
PV
| $5.03M | ﹤0.01% |
516,302
+389,477
| +307% | +$3.77M |
|
|
LADR
2814
Ladder Capital
LADR
$1.25B
| $5.03M | ﹤0.01% |
455,445
+341,247
| +299% | +$3.82M |
|
2815
Palantir
PLTR
$448B
| $5.03M | ﹤0.01% |
209,205
+152,478
| +269% | +$3.72M |
|
2816
Spok Holdings
SPOK
$223M
| $5.02M | ﹤0.01% |
491,150
+209,392
| +74% | +$1.88M |
|
|
PRVB
2817
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $5.01M | ﹤0.01% |
783,522
+219,834
| +39% | +$1.41M |
|
2818
CALL
Bally's
BALY
$476M
| $5.01M | ﹤0.01% |
+100,000
| New | +$4.88M |
|
2819
PUT
Hasbro
HAS
$13.3B
| $5.01M | ﹤0.01% |
+56,200
| New | +$5.46M |
|
2820
Valmont Industries
VMI
$9.19B
| $5.01M | ﹤0.01% |
21,318
+13,826
| +185% | +$3.29M |
|
2821
GXO Logistics
GXO
$5.46B
| $5M | ﹤0.01% |
+63,811
| New | +$5M |
|
|
TE
2822
T1 Energy
TE
$1.41B
| $5M | ﹤0.01% |
+507,028
| New | +$4.67M |
|
|
INST
2823
DELISTED
Instructure Holdings, Inc.
INST
| $5M | ﹤0.01% |
+221,243
| New | +$4.72M |
|
2824
Teladoc Health
TDOC
$1.18B
| $5M | ﹤0.01% |
39,408
-165,756
| -81% | -$24.1M |
|
|
MSPR
2825
DELISTED
MSP Recovery Inc
MSPR
| $4.99M | ﹤0.01% |
115
+107
| +1,338% | +$4.63M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.